MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy

被引:22
作者
Franklin, J. M. [1 ]
Anderson, E. M. [1 ]
Gleeson, F. V. [1 ]
机构
[1] Churchill Hosp, Oxford OX3 7LJ, England
关键词
COMPLETE CLINICAL-RESPONSE; PREOPERATIVE CHEMORADIATION; NONOPERATIVE TREATMENT; PATHOLOGICAL RESPONSE; TUMOR; THERAPY; CARCINOMA; PREDICTION; ACCURACY; SURVIVAL;
D O I
10.1016/j.crad.2011.11.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To describe the post-chemoradiotherapy magnetic resonance imaging (MRI) features of locally advanced rectal carcinoma (LARC) in which there has been a complete histopathological response to neoadjuvant chemoradiotherapy (CRT). MATERIALS AND METHODS: This retrospective cohort study was performed between January 2005 and November 2009 at a regional cancer centre. Consecutive patients with LARC and a histopathological complete response to long-course CRT were identified. Pre- and post-treatment MRI images were reviewed using a proforma for predefined features and response criteria. ymrT0 was defined as the absence of residual abnormality on MRI. RESULTS: Twenty patients were included in the study. Seven (35%) ypT0 tumours were ymrT0. All 13 ypT0 tumours not achieving ymrT0 appearances had a good radiological response, with at least 65% tumour reduction. The appearances were heterogeneous: in 11/13 patients the tumour was replaced by a region of at least 50% low signal on MRI, with 8/13 having >= 80% low signal, and 3/13 with 100% low signal. CONCLUSION: MRI may be useful in identifying a complete histopathological response. However, the MRI appearances of ypT0 tumours are heterogeneous and conventional MRI complete response criteria will not detect the majority of patients with a complete histopathological response. (C) 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 31 条
  • [21] Downstaging After Chemoradiotherapy for Locally Advanced Rectal Cancer: Is There More (Tumor) Than Meets the Eye?
    Mignanelli, Emilio D.
    Campos-Lobato, Luiz F.
    Stocchi, Luca
    Lavery, Ian C.
    Dietz, David W.
    [J]. DISEASES OF THE COLON & RECTUM, 2010, 53 (03) : 251 - 256
  • [22] Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y''u' and 'p' need 'mr' and 'ct'
    Moran, B.
    Brown, G.
    Cunningham, D.
    Daniels, I.
    Heald, R.
    Quirke, P.
    Sebag-Montefiore, D.
    [J]. COLORECTAL DISEASE, 2008, 10 (03) : 242 - 243
  • [23] Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer
    O'Neill, Brian D. P.
    Brown, Gina
    Heald, R. J.
    Cunningham, David
    Tait, Diana M.
    [J]. LANCET ONCOLOGY, 2007, 8 (07) : 625 - 633
  • [24] Rectal carcinoma: Prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging
    Okizuka, H
    Sugimura, K
    Yoshizako, T
    Kaji, Y
    Wada, A
    [J]. JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1996, 6 (03): : 465 - 471
  • [25] Preoperative versus postoperative chemoradiotherapy for rectal cancer
    Sauer, R
    Becker, H
    Hohenberger, W
    Rodel, C
    Wittekind, C
    Fietkau, R
    Martus, P
    Tschmelitsch, J
    Hager, E
    Hess, CF
    Karstens, JH
    Liersch, T
    Schmidberger, H
    Raab, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) : 1731 - 1740
  • [26] Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer
    Suarez, J.
    Vera, R.
    Balen, E.
    Gomez, M.
    Arias, F.
    Lera, J. M.
    Herrera, J.
    Zazpe, C.
    [J]. COLORECTAL DISEASE, 2008, 10 (06) : 563 - 568
  • [27] Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer
    Suppiah, A.
    Hunter, I. A.
    Cowley, J.
    Garimella, V.
    Cast, J.
    Hartley, J. E.
    Monson, J. R. T.
    [J]. COLORECTAL DISEASE, 2009, 11 (03) : 249 - 253
  • [28] Can rectal cancers with pathologic to after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?
    Tulchinsky, H
    Rabau, M
    Shacham-Shemueli, E
    Goldman, G
    Geva, R
    Inbar, M
    Klausner, JM
    Figer, A
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) : 347 - 352
  • [29] Rectal cancer: MR Imaging in local staging - Is gadolinium-based contrast material helpful?
    Vliegen, RFA
    Beets, GL
    von Meyenfeldt, MF
    Kessels, AGH
    Lemaire, EEMT
    van Engelshoven, JMA
    Beets-Tan, RGH
    [J]. RADIOLOGY, 2005, 234 (01) : 179 - 188
  • [30] Longitudinal Assessment of Quality of Life in Rectal Cancer Patients With or Without Stomas Following Primary Resection
    Yau, Thomas
    Watkins, David
    Cunningham, David
    Barbachano, Yolanda
    Chau, Ian
    Chong, Geoffrey
    [J]. DISEASES OF THE COLON & RECTUM, 2009, 52 (04) : 669 - 677